Form D · Biotechnology

Spinal Singularity, Inc.

San Clemente, CA · CIK 0001717150

Offering snapshot reported May 22, 2018 · SEC filing

Reported sold
$2M
Offering amount: $2M
Investors reported
29
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 19, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$998K$2MApr 2, 2018: $907,756.00Apr 2, 2018May 22, 2018: $1,996,108.00May 22, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$907,756 → $1,996,108
  • Reported investors6 → 29

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 22, 2018Amendment$1,996,108$1,088,352vs Apr 2, 201829SEC filing
Apr 2, 2018Initial$907,756No comparison6SEC filing
Sep 27, 2017Initial$2,928,731No comparison38SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-309111

Source: Form D, filed May 22, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth Baker Director
Bill Colone Director, Executive
Andrew Gilbert Director
Derek Herrera Director, Executive
Christopher Jennings Director
David Kaysen Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
105 Avenida De La Estrella, Suite 3
San Clemente, CA, 92672